◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › P › PMED

PiùMedical S.p.A. (PMED) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Pharmaceutical Retailers · DATA UPDATED 2026-10-03

PiùMedical S.p.A. (PMED) operates in the Pharmaceutical Retailers industry and is headquartered in Castronno, Italy with about 71 employees. Its market capitalization is roughly €35 million.

PiùMedical S.p.A. owns and operates a retail pharmaceutical chain in Lombardy region in Italy.

Interactive charts & full statements → Open the PMED valuation workbench →

PMED Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-31
Total Revenue—€26M€25M
Gross Profit—€10M€9M
Operating Income (EBIT)—€2M€3M
Net Income—€1M€2M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PMED Free Cash Flow History

PMED Balance Sheet History

Balance sheet2024-12-312023-12-31
Total Assets€38M€38M
Total Liabilities€14M€16M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PMED viewer.

Other Companies in Pharmaceutical Retailers

← PMECAll “P” companiesPMEH →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.